perifosine has been researched along with ATLL in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cappellini, A; Chiarini, F; Del Sole, M; Follo, MY; Gaboardi, GC; Mantovani, I; Martelli, AM; McCubrey, JA; Mongiorgi, S | 1 |
1 other study(ies) available for perifosine and ATLL
Article | Year |
---|---|
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Caspases; Cell Survival; Cytochromes c; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Enzyme Activation; Flow Cytometry; Humans; Immunoenzyme Techniques; JNK Mitogen-Activated Protein Kinases; Leukemia-Lymphoma, Adult T-Cell; Membrane Microdomains; Mitochondria; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured; Vinblastine | 2008 |